US FDA: fake warning letters being issued to consumers

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1712卷 / 1期

关键词：

D O I：

10.1007/s40278-018-49295-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：6 / 6

相关论文

共 50 条

[21] FDA warning letters give additional details
不详
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2009, 235 (10): : 1117 - 1117
[22] The US FDA is warning consumers and healthcare providers against using bismacine, also known as chromacine
Reactions Weekly, 2006, 1112 (1) : 3 - 3
[23] US FDA issues astemizole warning
Reactions Weekly, 1998, 688 (1) : 2 - 2
[24] US FDA issues warning on TriCitrasol
Reactions Weekly, 2000, 798 (1) : 2 - 2
[25] A REVIEW OF FDA WARNING LETTERS AND NOTICES OF VIOLATION ISSUED FOR PATIENT REPORTED OUTCOMES PROMOTIONAL CLAIMS BETWEEN 2006-2012
Symonds, T.
Hackford, C.
Abraham, L.
VALUE IN HEALTH, 2014, 17 (03) : A165 - A165
[26] A Review of FDA Warning Letters and Notices of Violation Issued for Patient-Reported Outcomes Promotional Claims between 2006 and 2012
Symonds, Tara
Hackford, Claire
Abraham, Lucy
VALUE IN HEALTH, 2014, 17 (04) : 433 - 437
[27] FDA issues new clinical research warning letters
不详
JOURNAL OF INVESTIGATIVE MEDICINE, 2002, 50 (05) : 344 - 345
[28] Responding to FDA-483s and warning letters
Chesney, DL
Kelly, AE
BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 1998, 11 (10): : 26 - 29
[29] The value of fda 483s and warning letters
Pharmaceutical Technology, 2021, 45 (07)
[30] A Communication Effectiveness Study of the FDA GMP Warning Letters
Bao, Yiyi
Zheng, Qiang
JOURNAL OF PHARMACEUTICAL INNOVATION, 2024, 19 (03)

← 1 2 3 4 5 →